$2.99+0.03 (+1.01%)
SBC Medical Group Holdings Incorporated, together with its subsidiaries, provides management services to cosmetic treatment centers in Japan, Vietnam, the United States, and Singapore.
SBC Medical Group Holdings Incorporated in the Industrials sector is trading at $2.99. Wall Street consensus targets $8.50 (4 analysts), implying a +184.3% move over the next 12 months. The stock is currently near its 52-week low of $2.78, remaining 23.7% below its 200-day moving average. On fundamentals, Piotroski 3/9 flags weak fundamentals. The Whystock Score of 35/100 signals elevated caution as multiple indicators diverge.
Simplified model based on P/E and ROE. Not a substitute for full valuation analysis. Data may be delayed. See our Terms.
SBC Medical Group Holdings Incorporated, together with its subsidiaries, provides management services to cosmetic treatment centers in Japan, Vietnam, the United States, and Singapore. The company offers advertising and marketing services across soci...
As you might know, SBC Medical Group Holdings Incorporated ( NASDAQ:SBC ) just kicked off its latest quarterly results...
SBC Medical Group Holdings Inc (SBC) reports a 9% revenue decline but shows strong underlying growth and strategic expansion in non-aesthetic categories.
SBC Medical Group (NASDAQ:SBC) reported first-quarter 2026 revenue of $43 million, down 9% from a year earlier, as management said prior fee structure revisions continued to weigh on reported results even as underlying clinic activity improved. Yuya Yoshida, chief financial officer of SBC Medical G
SBC Medical Group Holdings Incorporated (NYSE:SBC) is among the 12 Cheap Penny Stocks to Invest In Now. On March 27, SBC Medical Group Holdings Incorporated (NYSE:SBC) reported fourth-quarter revenue of $40 million, below the consensus estimate of $45.44 million. Management attributed the year-over-year revenue decline to deliberate structural changes, including a 2024 business restructuring and revisions […]
SBC Medical Group Holdings Inc (SBC) reports strong profitability and strategic global expansion despite a decline in full-year revenue.